Member access

4-Traders Homepage  >  Shares  >  Nasdaq  >  Anacor Pharmaceuticals Inc    ANAC   US0324201013

 SummaryQuotesChart AnalysisNewsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
04/16/2014 04/17/2014 04/21/2014 04/22/2014 04/23/2014 Date
15.37(c) 15.51(c) 16.105(c) 17.62(c) 16.83(c) Last
491 580 424 824 299 475 583 820 413 593 Volume
+2.19% +0.91% +3.84% +9.41% -4.48% Change
More quotes
Company
Anacor Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on discovering, developing and commercializing novel small-molecule therapeutics derived from its boron chemistry platform. The company has discovered seven compounds that are currently in development including its lead... 
Sector
Biotechnology
Calendar
05/08Earnings Release
Surperformance© rating of Anacor Pharmaceuticals Inc
Trading Rating : Investor Rating :
More about the company
Chart ANACOR PHARMACEUTICALS INC
Duration : Period :
Anacor Pharmaceuticals Inc Technical Analysis Chart | ANAC | US0324201013 | 4-Traders
Full-screen chart
Financials ($)
Sales 2014 21,7 M
EBIT 2014 -70,8 M
Net income 2014 -72,8 M
Debt 2014 -
Yield 2014 -
Sales 2015 72,3 M
EBIT 2015 -47,7 M
Net income 2015 -49,2 M
Debt 2015 -
Yield 2015 -
PER 2014 -
PER 2015
Capi. / Sales 2014 33,9x
Capi. / Sales 2015 10,2x
Capitalization 737 M
More Financials
Latest news on ANACOR PHARMACEUTICALS INC
04/10 THURSDAY SECTOR LAGGARDS : Biotechnology, Drugs
04/10 ANACOR PHARMACEUTICALS : Announces First Patient Enrolled in Phase 3 Trial of AN..
04/09 ANACOR PHARMACEUTICALS : Healthcare Companies Report Regulatory Affirmations, MP..
03/31 ANACOR PHARMACEUTICALS : Announces First Patient Enrolled in Phase 3 Trial of AN..
03/26 ANACOR PHARMACEUTICALS : Appoints Paul L. Berns as Chief Executive Officer
03/20 ANACOR PHARMACEUTICALS : Entry into a Material Definitive Agreement, Termination..
03/19 ANACOR PHARMACEUTICALS : Reports 2013 Fourth Quarter and Year-End Financial Resu..
03/19 ANACOR PHARMACEUTICALS : Announces Appointment of Vince Ippolito as Chief Commer..
03/19 ANACOR PHARMACEUTICALS : Appoints Paul L. Berns as Chief Executive Officer
03/17 ANACOR PHARMACEUTICALS : Posts 2013 Fourth Quarter and Year-End Financial Result..
03/17 ANACOR PHARMACEUTICALS : Issues 2013 4Q and Year-End Financial Results
03/17 ANACOR PHARMACEUTICALS : Reports 2013 Fourth Quarter Earnings
More news
Comments 
Advertisement
Technical analysis trends
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Technical analysis
Income Statement Evolution
Anacor Pharmaceuticals Inc : Income Statement Evolution
More Financials
EPS Revisions
Anacor Pharmaceuticals Inc : EPS Revisions
More Estimates Revisions
Dynamic quotes  
ON
| OFF